[Effect of colestipol on plasma lipids in patients affected by type Ii primary hyperlipoproteinaemia (author's transl)].
D000328:Adult; D000368:Aged; D002784:Cholesterol / Q000097:blood; D003084:Colestipol / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011073:Polyamines / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
D011073:Polyamines; D014280:Triglycerides; D002784:Cholesterol; D003084:Colestipol
Hyperlipoprotéinémie primitive de type II. Traitement durant 18 mois par colestipol.